Skip to main content
Christoph Bock and his group at the ÖAW’s ceremony on 8 June 2022 (© CeMM).

Christoph Bock received the prestigious Erwin Schrödinger Award of the Austrian Academy of Sciences

CeMM congratulates Principal Investigator Christoph Bock on being awarded the Erwin Schrödinger Award of the Austrian Academy of Sciences (ÖAW) for his pioneering achievements in the field of single-cell sequencing and epigenetics. The Erwin Schrödinger Award together with the Wilhelm Hartel Prize are the highest prizes awarded annually by the ÖAW.

Epigenetics have been one of the main interests of bioinformatician Christoph Bock’s biomedical research, he looks beyond DNA and the processes that control the activity and availability of the human genes. Christoph Bock, an expert in complex data analysis, conducts interdisciplinary research…

Read more
New CeMM Principal Investigator André Rendeiro (© Laura Alvarez / CeMM).

New CeMM Principal Investigator André Rendeiro

On 1 June 2022, André Rendeiro joins CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, as new Principal Investigator. André Rendeiro will employ computational approaches to understand human aging from a molecular, cellular and tissue level to the individual and population scale. His group will contribute to expanding CeMM’s expertise in the field of spatial and computational biology.

André Rendeiro studied Cell and Molecular Biology in Portugal, Austria and Norway. He earned his PhD at CeMM in the group of Principal Investigator Christoph Bock, where he developed methods for high-throughput cellular…

Read more
From L to R: Giulio Superti-Furga, Helga Nowotny, Christiane Druml, Markus Müller, Alison Abbott and Heinz Faßmann (© Franzi Kreis / CeMM).

CeMM 15th Anniversary Symposium

On 20-21 May 2022, CeMM hosted the Scientific Anniversary Symposium on the occasion of the 15th anniversary of our institute. The conference on “Molecular medicine from signal transduction to societal impact: A journey through challenging territories” included an exciting line-up of renowned speakers working in the field of molecular biology across Europe and overseas. During the two-day event, 300 participants from the international scientific community, academia, industry, CeMM Faculty, colleagues and alumni, as well as other partner institutes and collaborators gathered at the House of Industry to discuss science, the development of new…

Read more
Prof. Wendell Lim at the 15th CeMM Landsteiner Lecture (Ⓒ Klaus Pichler / CeMM).

15th CeMM Landsteiner Lecture by Wendell Lim and the 2021 Denise P. Barlow Award Ceremony

On 9 May 2022, CeMM hosted the 15th Landsteiner Lecture with keynote speaker Wendell Lim, Professor and Chair of the Department of Cellular and Molecular Pharmacology at the University of California San Francisco (USA), and Director of the Nanomedicine Development Center and the Synthetic Biology Engineering Research Center.

The event opened with the first piece of the famous set “3 Old Viennese Dances”, composed by Austrian-American violinist Fritz Kreisler, and performed by the musicians Kirill Kobanschenko, first violinist with the Philharmonic Orchestra, Florian Eggner, a cellist who plays in all the major houses, and Aurore Nozomi -…

Read more

CeMM Research Report 2021

RESEARCH FORTE is used to create knowledge and awareness. This particular package contains information and data about humans and their health. It is a research concentrate of science. Behind every medical treatment and any pharmaceutical pill, no matter how small and simple-looking, there is a mountain of research.

Look inside the box and see what's inside RESEARCH FORTE. Please read the package insert carefully!

Discover the CeMM Research Report 2021.

If you would like to receive a hard copy of our Research Report, please fill in the registration form.

Read more

Time for Change: CeMM unveils new corporate identity

At CeMM, we are constantly evolving and growing, always striving to improve ourselves and our research in line with the latest scientific research discoveries. With a modern and fresh new look, and a dedicated claim, we wish to take up the new challenges of our time and continue our path of medical innovation and discovery. 

After 15 years of pioneering work, we want to see our achievements, our constant development, our innovations in medicine also in our corporate identity. Our institute aims at achieving maximum scientific innovation in molecular medicine with a focus on societally important diseases. We are unveiling a new corporate…

Read more
CeMM colleagues during the Scientific Recess. (© Markus Kohlmayr / CeMM).

CeMM Scientific Recess 2022

After two years of pandemic, CeMM had the chance again to organize in person its annual Scientific Recess, from 4 to 6 April 2022, in Windischgarsten, a beautiful location surrounded by nature in Upper Austria. This year’s main goal was to offer a space for CeMM colleagues to reconnect with one another and find out more about their research work. Following all health and safety measures, a group of 60 colleagues representing all CeMM groups and adjunct groups came together to discuss new projects and scientific topics relevant to the institute, and further strengthen collaboration and cooperation among the different laboratories at CeMM. 

Du…

Read more

CeMM stands in solidarity with Ukraine

CeMM strongly condemns the invasion of Ukraine and wholeheartedly wishes to express solidarity with the Ukrainian people in these difficult times. Together with the Austrian Academy of Sciences and our partners in the EU-LIFE alliance, we would like to support the scientific community in Ukraine.

CeMM supports the following initiatives for scientists from Ukraine:

  • EMBO's Solidarity with Ukraine: A list of life scientists across Europe and beyond offering to host Ukrainian researchers in their labs.
  • Science for Ukraine: Platforms offering to host Ukrainian researchers in labs across Europe and beyond. CeMM offers up to five fully funded…
Read more
Thijn Brummelkamp (©CeMM).

CeMM bids farewell to Thijn Brummelkamp

Adjunct Principal Investigator Thijn Brummelkamp’s affiliation came to an end after having been associated with CeMM for ten years. We would like to sincerely thank him for a great collaboration on the scientific front and fruitful exchanges and constant engagement with the CeMM community.

Thijn Brummelkamp received his Msc in biology from the Free University in Amsterdam in 1998. He did his graduate research at The Netherlands Cancer Institute in Amsterdam in the group of René Bernards and received his PhD cum laude from Utrecht University in 2003. After his PhD he was appointed as group leader at the Whitehead Institute for Biomedical…

Read more

Become a Starting Principal Investigator at CeMM in Vienna

Research Area: Biology of Human Aging/Healthy Lifespan Expansion

The time is ripe for brand new approaches to the phenomenon of human aging and the ambition of healthy lifespan expansion. Access to large deep phenotypic and genomic datasets and new powerful imaging, molecular and computational approaches call for initiatives in an area that for a long time has been captive of single mechanistic theories. At CeMM, we propose a completely fresh look with great intellectual rigor matched with unconventional perspectives. Two new hires on the subject will join a faculty already working on molecular-medical aspects of epigenetic regulation,…

Read more